RhumbLine Advisers’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.74M | Sell |
|
|||||
|
2025
Q2 | $1.01M | Buy |
|
|||||
|
2025
Q1 | $1.06M | Buy |
|
|||||
|
2024
Q4 | $613K | Buy |
|
|||||
|
2024
Q3 | $495K | Sell |
|
|||||
|
2024
Q2 | $427K | Buy |
|
|||||
|
2024
Q1 | $393K | Buy |
|
|||||
|
2023
Q4 | $403K | Sell |
|
|||||
|
2023
Q3 | $323K | Sell |
|
|||||
|
2023
Q2 | $456K | Buy |
|
|||||
|
2023
Q1 | $282K | Buy |
|
|||||
|
2022
Q4 | $221K | Buy |
|
|||||
|
2022
Q3 | $254K | Buy |
|
|||||
|
2022
Q2 | $233K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $188K | Sell |
|
|||||
|
2020
Q4 | $213K | Buy |
|
|||||
|
2020
Q3 | $223K | Sell |
|
|||||
|
2020
Q2 | $121K | Buy |
|
|||||
|
2020
Q1 | $61K | Hold |
|
|||||
|
2019
Q4 | $220K | Buy |
|
|||||
|
2019
Q3 | $303K | Sell |
|
|||||
|
2019
Q2 | $353K | Buy |
|
|||||
|
2019
Q1 | $232K | Buy |
|